327 related articles for article (PubMed ID: 19284928)
21. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
Keck PE; Corya SA; Altshuler LL; Ketter TA; McElroy SL; Case M; Briggs SD; Tohen M
J Clin Psychiatry; 2005 May; 66(5):611-6. PubMed ID: 15889948
[TBL] [Abstract][Full Text] [Related]
22. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
Brown E; Dunner DL; McElroy SL; Keck PE; Adams DH; Degenhardt E; Tohen M; Houston JP
Int J Neuropsychopharmacol; 2009 Jul; 12(6):773-82. PubMed ID: 19079815
[TBL] [Abstract][Full Text] [Related]
23. Effect of comorbid anxiety on treatment response in bipolar depression.
Tohen M; Calabrese J; Vieta E; Bowden C; Gonzalez-Pinto A; Lin D; Xu W; Corya S
J Affect Disord; 2007 Dec; 104(1-3):137-46. PubMed ID: 17512607
[TBL] [Abstract][Full Text] [Related]
24. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
[TBL] [Abstract][Full Text] [Related]
25. Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study.
Gelenberg AJ; Dunner DL; Rothschild AJ; Pedersen R; Dorries KM; Ninan PT
J Nerv Ment Dis; 2013 Apr; 201(4):266-73. PubMed ID: 23538970
[TBL] [Abstract][Full Text] [Related]
26. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
Perlis RH; Adams DH; Fijal B; Sutton VK; Farmen M; Breier A; Houston JP
J Clin Psychiatry; 2010 May; 71(5):599-605. PubMed ID: 20021991
[TBL] [Abstract][Full Text] [Related]
27. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
Tohen M; Case M; Trivedi MH; Thase ME; Burke SJ; Durell TM
J Clin Psychiatry; 2010 Apr; 71(4):451-62. PubMed ID: 20361905
[TBL] [Abstract][Full Text] [Related]
28. Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.
Shelton C; Entsuah R; Padmanabhan SK; Vinall PE
Int Clin Psychopharmacol; 2005 Jul; 20(4):233-8. PubMed ID: 15933485
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico.
Tamayo JM; Sutton VK; Mattei MA; Diaz B; Jamal HH; Vieta E; Zarate CA; Fumero I; Tohen M
J Clin Psychopharmacol; 2009 Aug; 29(4):358-61. PubMed ID: 19593175
[TBL] [Abstract][Full Text] [Related]
30. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese JR; Elhaj O; Gajwani P; Gao K
J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
[TBL] [Abstract][Full Text] [Related]
31. Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis.
Houston JP; Lau K; Aris V; Liu W; Fijal BA; Heinloth AN; Perlis RH
J Clin Psychiatry; 2012 Jun; 73(6):878-85. PubMed ID: 22480387
[TBL] [Abstract][Full Text] [Related]
32. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
Matthews JD; Bottonari KA; Polania LM; Mischoulon D; Dording CM; Irvin R; Fava M
J Clin Psychiatry; 2002 Dec; 63(12):1164-70. PubMed ID: 12523877
[TBL] [Abstract][Full Text] [Related]
33. Olanzapine plus fluoxetine for bipolar disorder: a systematic review and meta-analysis.
Silva MT; Zimmermann IR; Galvao TF; Pereira MG
J Affect Disord; 2013 Apr; 146(3):310-8. PubMed ID: 23218251
[TBL] [Abstract][Full Text] [Related]
34. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
Perlis RH; Baker RW; Zarate CA; Brown EB; Schuh LM; Jamal HH; Tohen M
J Clin Psychiatry; 2006 Nov; 67(11):1747-53. PubMed ID: 17196055
[TBL] [Abstract][Full Text] [Related]
35. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
36. Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression.
Dubé S; Tollefson GD; Thase ME; Briggs SD; Van Campen LE; Case M; Tohen M
Bipolar Disord; 2007 Sep; 9(6):618-27. PubMed ID: 17845277
[TBL] [Abstract][Full Text] [Related]
37. Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia.
Tzanakaki M; Guazzelli M; Nimatoudis I; Zissis NP; Smeraldi E; Rizzo F
Int Clin Psychopharmacol; 2000 Jan; 15(1):29-34. PubMed ID: 10836283
[TBL] [Abstract][Full Text] [Related]
38. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group.
Clerc GE; Ruimy P; Verdeau-Pallès J
Int Clin Psychopharmacol; 1994 Sep; 9(3):139-43. PubMed ID: 7814822
[TBL] [Abstract][Full Text] [Related]
39. Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study.
Corya SA; Andersen SW; Detke HC; Kelly LS; Van Campen LE; Sanger TM; Williamson DJ; Dubé S
J Clin Psychiatry; 2003 Nov; 64(11):1349-56. PubMed ID: 14658950
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode.
Amsterdam J
J Clin Psychopharmacol; 1998 Oct; 18(5):414-7. PubMed ID: 9790160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
